Cite
HARVARD Citation
Torigoe, H. et al. (2018). Therapeutic strategies for afatinib‐resistant lung cancer harboring HER2 alterations. Cancer science. 109 (5), pp. 1493-1502. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Torigoe, H. et al. (2018). Therapeutic strategies for afatinib‐resistant lung cancer harboring HER2 alterations. Cancer science. 109 (5), pp. 1493-1502. [Online].